Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gary S. Marshall, Victoria Abbing-Karahagopian, Helen S. Marshall, Silvia Cenci, James H. Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff & Woo-Yun Sohn. (2023) A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB). Expert Review of Vaccines 22:1, pages 530-544.
Read now
Read now
Myron Christodoulides, Maria Victoria Humbert & John E Heckels. (2021) The potential utility of liposomes for Neisseria vaccines. Expert Review of Vaccines 20:10, pages 1235-1256.
Read now
Read now
Cecilia Fazio, Alessia Biolchi, Arianna Neri, Sara Tomei, Paola Vacca, Luigina Ambrosio, Annapina Palmieri, Elena Mori, Rita La Gaetana, Mariagrazia Pizza, Marzia Monica Giuliani, Laura Serino & Paola Stefanelli. (2021) Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy. Human Vaccines & Immunotherapeutics 17:7, pages 2225-2231.
Read now
Read now
Peter T. Beernink. (2020) Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein. Human Vaccines & Immunotherapeutics 16:3, pages 703-712.
Read now
Read now
Paul Balmer, Johannes Beeslaar, Jamie Findlow & Amit Srivastava. (2020) Understanding immunogenicity assessments for meningococcal serogroup B vaccines. Postgraduate Medicine 132:2, pages 184-191.
Read now
Read now
Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro & Federico Martinón-Torres. (2019) Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance 12, pages 3169-3188.
Read now
Read now
Jamie Findlow, Charles Nuttens & Paula Kriz. (2019) Introduction of a second MenB vaccine into Europe – needs and opportunities for public health. Expert Review of Vaccines 18:3, pages 225-239.
Read now
Read now
Robert G. K. Donald, Julio Cesar Hawkins, Li Hao, Paul Liberator, Thomas R. Jones, Shannon L. Harris, John L. Perez, Joseph J. Eiden, Kathrin U. Jansen & Annaliesa S. Anderson. (2017) Meningococcal serogroup B vaccines: Estimating breadth of coverage. Human Vaccines & Immunotherapeutics 13:2, pages 255-265.
Read now
Read now
Articles from other publishers (61)
Yoshiyuki Manabe, Brandon Gárate-Reyes, Keita Ito, Ramón Hurtado-Guerrero, Kazuya Kabayama & Koichi Fukase. (2024) Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2. Chemical Communications 60:29, pages 3946-3949.
Crossref
Crossref
Zhizhou Tan, Juan Xu, Jie Che, Li Xu, Dongshan Yan, Maojun Zhang & Zhujun Shao. (2024) Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria meningitidis in China. Microorganisms 12:3, pages 481.
Crossref
Crossref
August Mikucki & Charlene M. Kahler. (2023) Microevolution and Its Impact on Hypervirulence, Antimicrobial Resistance, and Vaccine Escape in Neisseria meningitidis. Microorganisms 11:12, pages 3005.
Crossref
Crossref
Xuemei He, Cai He, Weiqi Hong, Jingyun Yang & Xiawei Wei. (2023) Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development. Medicinal Research Reviews 43:4, pages 932-971.
Crossref
Crossref
Luke Smithers, Oksana Degtjarik, Dietmar Weichert, Chia-Ying Huang, Coilín Boland, Katherine Bowen, Abraham Oluwole, Corinne Lutomski, Carol V. Robinson, Eoin M. Scanlan, Meitian Wang, Vincent Olieric, Moran Shalev-Benami & Martin Caffrey. (2023)
Structure snapshots reveal the mechanism of a bacterial membrane lipoprotein
N
-acyltransferase
. Science Advances 9:26.
Crossref
Crossref
Ola Brønstad Brynildsrud, Sara Viksmoen Watle, Kristian Alfsnes & Dominique A. Caugant. (2023) Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic. International Journal of Infectious Diseases 131, pages 130-139.
Crossref
Crossref
Andrea De Vito, Agnese Colpani, Mattia Trunfio, Vito Fiore, Giulia Moi, Marco Fois, Nicola Leoni, Stefano Ruiu, Sergio Babudieri, Andrea Calcagno & Giordano Madeddu. (2023) Living with HIV and Getting Vaccinated: A Narrative Review. Vaccines 11:5, pages 896.
Crossref
Crossref
Viola Viviani, Adele Fantoni, Sara Tomei, Sara Marchi, Enrico Luzzi, Margherita Bodini, Alessandro Muzzi, Marzia M. Giuliani, Domenico Maione, Jeremy P. Derrick, Isabel Delany, Mariagrazia Pizza, Alessia Biolchi & Erika Bartolini. (2023) OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans. npj Vaccines 8:1.
Crossref
Crossref
Alessandra Lo Presti, Anna Carannante, Cecilia Fazio, Arianna Neri, Paola Vacca, Luigina Ambrosio, Florigio Lista, Silvia Fillo & Paola Stefanelli. (2023) FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017. PLOS ONE 18:2, pages e0277976.
Crossref
Crossref
Yoshiyuki Manabe & Koichi Fukase. 2023. Glycolipids. Glycolipids
55
72
.
Rafał Jabłuszewski & Agnieszka Wyszyńska. (2022) Współczesne Metody Identyfikacji Białkowych Antygenów Szczepionkowych. Postępy Mikrobiologii - Advancements of Microbiology 61:4, pages 211-221.
Crossref
Crossref
Dylan Sheerin, Christina Dold, Laura Silva-Reyes, Aline Linder, Andrew J. Pollard & Christine S. Rollier. (2022) Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus. Cell & Bioscience 12:1.
Crossref
Crossref
Renzo Alfini, Brunella Brunelli, Erika Bartolini, Martina Carducci, Enrico Luzzi, Francesca Ferlicca, Scilla Buccato, Barbara Galli, Paola Lo Surdo, Maria Scarselli, Giacomo Romagnoli, Elena Cartocci, Domenico Maione, Silvana Savino, Francesca Necchi, Isabel Delany & Francesca Micoli. (2022) Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA. Vaccines 10:8, pages 1182.
Crossref
Crossref
Tsung-Che Chang, Yoshiyuki Manabe, Keita Ito, Ryuku Yamamoto, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Yukari Fujimoto, Chun-Cheng Lin & Koichi Fukase. (2022) Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope. RSC Advances 12:29, pages 18985-18993.
Crossref
Crossref
Vasilica Ungureanu. (2022) Essential things to know about meningococcal disease and its prevention. Medic.ro 1:145, pages 22.
Crossref
Crossref
Shubhranshu Zutshi, Sunil Kumar, Prashant Chauhan & Bhaskar Saha. 2022. Vaccine Design. Vaccine Design
57
91
.
Luke Smithers, Samir Olatunji & Martin Caffrey. (2021) Bacterial Lipoprotein Posttranslational Modifications. New Insights and Opportunities for Antibiotic and Vaccine Development. Frontiers in Microbiology 12.
Crossref
Crossref
Himadri B. Thapa, Anna M. Müller, Andrew Camilli & Stefan Schild. (2021) An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Irum Syed & R. Mark Wooten. (2021) Interactions Between Pathogenic Burkholderia and the Complement System: A Review of Potential Immune Evasion Mechanisms. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Alessandra Facchetti, Jun X. Wheeler, Caroline Vipond, Gail Whiting, Hayley Lavender, Ian M. Feavers, Martin C. J. Maiden & Sunil Maharjan. (2021) Factor H binding protein (fHbp)-mediated differential complement resistance of a serogroup C Neisseria meningitidis isolate from cerebrospinal fluid of a patient with invasive meningococcal disease. Access Microbiology 3:9.
Crossref
Crossref
Henju Marjuki, How-Yi Chang, Nadav Topaz, Melissa J. Whaley, Jeni Vuong, Alexander Chen, Laurel T. Jenkins, Fang Hu, Susanna Schmink, Adam C. Retchless, Jennifer D. Thomas, Anna M. Acosta, Lucy A. McNamara, Heidi M. Soeters, Sarah Mbaeyi & Xin Wang. (2021) Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015–2016. mBio 12:3.
Crossref
Crossref
И.А. Карпов. (2021) An Uninvited Guest: Meningococcal Infection – Current Aspects of Epidemiology, Clinic and Prevention. Клиническая инфектология и паразитология:1, pages 39-53.
Crossref
Crossref
Raquel Abad, Cristina García-Amil, Carmen Navarro, Elena Martín, Ariadna Martín-Díaz & Julio A Vázquez. (2021) Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015–2018: Evolution of the vaccine antigen factor H binding protein (FHbp). Journal of Infection 82:4, pages 37-44.
Crossref
Crossref
Jeroen Pollet, Wen-Hsiang Chen & Ulrich Strych. (2021) Recombinant protein vaccines, a proven approach against coronavirus pandemics. Advanced Drug Delivery Reviews 170, pages 71-82.
Crossref
Crossref
Raymond S. W. Tsang. (2021) A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Streptococcus agalactiae. Microorganisms 9:2, pages 449.
Crossref
Crossref
Koichi Fukase. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
166
184
.
Yoshiyuki Manabe, Atushi Shimoyama, Kazuya Kabayama & Koichi Fukase. 2021. Middle Molecular Strategy. Middle Molecular Strategy
3
20
.
Yoshiyuki Manabe, Tsung-Che Chang & Koichi Fukase. (2020) Recent advances in self-adjuvanting glycoconjugate vaccines. Drug Discovery Today: Technologies 37, pages 61-71.
Crossref
Crossref
Anna Carannante, Cecilia Fazio, Arianna Neri, Florigio Lista, Silvia Fillo, Andrea Ciammaruconi, Paola Vacca & Paola Stefanelli. (2020) Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014–2017. PLOS ONE 15:11, pages e0241793.
Crossref
Crossref
Stephen A. Clark & Ray Borrow. (2020) Herd Protection against Meningococcal Disease through Vaccination. Microorganisms 8:11, pages 1675.
Crossref
Crossref
Taku Aiga, Yoshiyuki Manabe, Keita Ito, Tsung‐Che Chang, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Ayane Miura, Hiroto Furukawa, Hiroshi Inaba, Kazunori Matsuura & Koichi Fukase. (2020) Immunological Evaluation of Co‐Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self‐Adjuvanting Anti‐Breast‐Cancer Vaccine Candidates. Angewandte Chemie International Edition 59:40, pages 17705-17711.
Crossref
Crossref
Taku Aiga, Yoshiyuki Manabe, Keita Ito, Tsung‐Che Chang, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Ayane Miura, Hiroto Furukawa, Hiroshi Inaba, Kazunori Matsuura & Koichi Fukase. (2020) Immunological Evaluation of Co‐Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self‐Adjuvanting Anti‐Breast‐Cancer Vaccine Candidates. Angewandte Chemie 132:40, pages 17858-17864.
Crossref
Crossref
Olof Säll, Emma Olofsson & Susanne Jacobsson. (2020) High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines. Vaccine 38:28, pages 4374-4378.
Crossref
Crossref
Raymond S. W. Tsang, Dennis K. S. Law, Rosita De Paola, Maria Giuliani, Maria Stella, Jianwei Zhou, Saul Deng, Giuseppe Boccadifuoco, Marzia Monica Giuliani & Laura Serino. (2020)
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
Neisseria meningitidis
Strains and Their Predicted Coverage by the 4CMenB Vaccine
. mSphere 5:2.
Crossref
Crossref
Joseph P. Fava, Brittany Stewart, Kathryn M. Dudzinski, Michelle Baker & Lucio Volino. (2018) Emerging Topics in Vaccine Therapeutics for Adolescents and Adults: An Update for Immunizing Pharmacists. Journal of Pharmacy Practice 33:2, pages 192-205.
Crossref
Crossref
Cynthia Burman, Justine Alderfer & Vincenza T. Snow. (2019) A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 270-281.
Crossref
Crossref
Aline Carvalho Azevedo, Nathércia Elena Chança Franco, Marcella Reis de Carvalho Rocha, Claudia Andrade, Maria Celeste Torres & Ivano de Filippis. (2020) Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780. Infection, Genetics and Evolution 78, pages 104079.
Crossref
Crossref
Vasilica Ungureanu. (2020) Invasive meningococcal disease – its importance in human pathology and its prevention. Medic.ro 2:134, pages 38.
Crossref
Crossref
Ronni A. G. da Silva, Andrey V. Karlyshev, Neil J. Oldfield, Karl G. Wooldridge, Christopher D. Bayliss, Ali Ryan & Ruth Griffin. (2019) Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates. Frontiers in Microbiology 10.
Crossref
Crossref
Alastair McAlpine & Manish Sadarangani. (2019) Meningitis vaccines in children: what have we achieved and where next?. Current Opinion in Infectious Diseases 32:5, pages 510-516.
Crossref
Crossref
Peter T. Beernink, Vianca Vianzon, Lisa A. Lewis, Gregory R. Moe & Dan M. Granoff. (2019) A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine. mBio 10:3.
Crossref
Crossref
Amaka M. Awanye, Chun-Mien Chang, Jun X. Wheeler, Hannah Chan, Leanne Marsay, Christina Dold, Christine S. Rollier, Louise E. Bird, Joanne E. Nettleship, Raymond J. Owens, Andrew J. Pollard & Jeremy P. Derrick. (2019) Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis. Scientific Reports 9:1.
Crossref
Crossref
Gabriela Trzewikoswki de Lima, Amanda Izeli Portilho & Elizabeth De Gaspari. (2019)
Cross-reactivity with Brazilian strains of
Neisseria meningitidis
B after immunization with outer membrane vesicles
. Therapeutic Advances in Vaccines and Immunotherapy 7, pages 251513551989482.
Crossref
Crossref
Caroline Cayrou & Christopher D. Bayliss. 2019. Neisseria meningitidis. Neisseria meningitidis
237
249
.
Jian Ma, Yunpeng Wang, Nuo Xu, Libo Jin, Jia Liu, Shaochen Xing & Xiaokun Li. (2018) Potential large scale production of meningococcal vaccines by stable overexpression of fHbp in the rice seeds. Protein Expression and Purification 152, pages 1-6.
Crossref
Crossref
Gabriela Trzewikoswki de Lima & Elizabeth De Gaspari. (2018) Individual variability in humoral response of immunized outbred mice and cross-reactivity with prevalent Brazilian Neisseria meningitidis strains. Biologicals 55, pages 19-26.
Crossref
Crossref
A.L. Wilkins & M.D. Snape. (2018) Emerging clinical experience with vaccines against group B meningococcal disease. Vaccine 36:36, pages 5470-5476.
Crossref
Crossref
Johannes Beeslaar, Judith Absalon, Paul Balmer, Amit Srivastava, Roger Maansson, Laura J. York & John L. Perez. (2018) Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Vaccine 36:28, pages 4004-4013.
Crossref
Crossref
Caroline Cayrou, Ayodeji A. Akinduko, Evgeny M. Mirkes, Jay Lucidarme, Stephen A. Clark, Luke R. Green, Helen J. Cooper, Julie Morrissey, Ray Borrow & Christopher D. Bayliss. (2018) Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines. PLOS ONE 13:5, pages e0197186.
Crossref
Crossref
Leszek Szenborn, Stan L. Block, Teresa Jackowska, Ryszard Konior, Diego D’Agostino, Igor Smolenov, Daniela Toneatto & Jo Anne Welsch. (2018) Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines. Pediatric Infectious Disease Journal 37:5, pages 475-482.
Crossref
Crossref
Luca Nompari, Serena Orlandini, Benedetta Pasquini, Cristiana Campa, Michele Rovini, Massimo Del Bubba & Sandra Furlanetto. (2018) Quality by design approach in the development of an ultra-high-performance liquid chromatography method for Bexsero meningococcal group B vaccine. Talanta 178, pages 552-562.
Crossref
Crossref
Patricia Anne O’Malley. (2018) Meningococcal Disease. Clinical Nurse Specialist 32:1, pages 15-18.
Crossref
Crossref
Theresa M. FioritoGrayson L. BairdNicole Alexander-ScottSuzanne BornscheinCatherine KelleherNan DuPenelope H. Dennehy. (2018) Adverse Events Following Vaccination With Bivalent rLP2086 (Trumenba®): An Observational, Longitudinal Study During a College Outbreak and a Systematic Review. Pediatric Infectious Disease Journal 37:1, pages e13-e19.
Crossref
Crossref
Gregory A. Price & Margaret C. Bash. (2018) Development of an FHbp-CTB holotoxin-like chimera and the elicitation of bactericidal antibodies against serogroup B Neisseria meningitidis. Vaccine 36:5, pages 644-652.
Crossref
Crossref
Liliana Costoya, Juan Marzoa, Carlos Ferreirós & Maria Teresa Criado. (2017)
Liposomes or traditional adjuvants: induction of bactericidal activity by the macrophage infectivity potentiator protein (Mip) of
Neisseria meningitidis
. APMIS 125:8, pages 725-731.
Crossref
Crossref
Jay Lucidarme, Aiswarya Lekshmi, Sydel R. Parikh, James E. Bray, Dorothea M. Hill, Holly B. Bratcher, Steve J. Gray, Anthony D. Carr, Keith A. Jolley, Jamie Findlow, Helen Campbell, Shamez N. Ladhani, Mary E. Ramsay, Martin C.J. Maiden & Ray Borrow. (2017) Frequent capsule switching in ‘ultra-virulent’ meningococci – Are we ready for a serogroup B ST-11 complex outbreak?. Journal of Infection 75:2, pages 95-103.
Crossref
Crossref
Arianna Marini, Omar Rossi, Maria Grazia Aruta, Francesca Micoli, Simona Rondini, Serafina Guadagnuolo, Isabel Delany, Ian R. Henderson, Adam F. Cunningham, Allan Saul, Calman A. MacLennan & Oliver Koeberling. (2017) Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1. PLOS ONE 12:7, pages e0181508.
Crossref
Crossref
Myron Christodoulides & John Heckels. (2017) Novel approaches to Neisseria meningitidis vaccine design. Pathogens and Disease 75:3.
Crossref
Crossref
Abigail I. Fish, Sean P. Riley, Birendra Singh, Kristian Riesbeck & Juan J. Martinez. (2017) The Rickettsia conorii Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Jamie Findlow & Ray Borrow. (2017) Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?. Pathogens and Disease 75:2.
Crossref
Crossref
Shakeel Mowlaboccus. (2017) Whole genome sequencing as a novel approach for characterising Neisseria meningitidis in Australia. Microbiology Australia 38:3, pages 142.
Crossref
Crossref